acetylcysteine and Cystadenocarcinoma, Serous

acetylcysteine has been researched along with Cystadenocarcinoma, Serous in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Årstad, E; Berndt, M; Gambhir, SS; Gendron, T; Glaser, M; Gowrishankar, G; Greenwood, HE; Hoehne, A; Koglin, N; Lewis, DY; Lythgoe, MF; Maddocks, ODK; McCormick, PN; Sander, K; Shuhendler, AJ; Witney, TH; Zhang, T	1

Other Studies

1 other study(ies) available for acetylcysteine and Cystadenocarcinoma, Serous

Article	Year
Assessment of Tumor Redox Status through ( Cancer research, 2019, 02-15, Volume: 79, Issue:4 Topics: Acetylcysteine; Amino Acid Transport System y+; Animals; Apoptosis; Cell Proliferation; Cystadenocarcinoma, Serous; Female; Fluorine Radioisotopes; Free Radical Scavengers; Glutamates; Humans; Metabolomics; Mice; Mice, Inbred BALB C; Mice, Nude; Ovarian Neoplasms; Oxidation-Reduction; Positron-Emission Tomography; Radiopharmaceuticals; tert-Butylhydroperoxide; Tumor Cells, Cultured; Xenograft Model Antitumor Assays	2019

Article

Year

Assessment of Tumor Redox Status through (

Cancer research, 2019, 02-15, Volume: 79, Issue:4

Topics: Acetylcysteine; Amino Acid Transport System y+; Animals; Apoptosis; Cell Proliferation; Cystadenocarcinoma, Serous; Female; Fluorine Radioisotopes; Free Radical Scavengers; Glutamates; Humans; Metabolomics; Mice; Mice, Inbred BALB C; Mice, Nude; Ovarian Neoplasms; Oxidation-Reduction; Positron-Emission Tomography; Radiopharmaceuticals; tert-Butylhydroperoxide; Tumor Cells, Cultured; Xenograft Model Antitumor Assays

2019